RDGL 0.05 Vivos Inc.
| Range: | 0.04119-0.255 | Vol Avg: | 1317952 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.03 | Cap: | 0.06B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Sep 02 1998 | Empoloyees: | 1 | ||
| CUSIP: | 92858K204 | CIK: | 0001449349 | ISIN: | US92858K2042 | Country: | US |
| CEO: | Dr. Michael K. Korenko Ph.D. | Website: | https://www.radiogel.com | ||||
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow